Alzamend Share Price

Alzamend Share Price

NASDAQ: ALZN | Micro Cap | Healthcare
$0.76
+$0.76 (--%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Alzamend Stock Performance

Open
$0.89
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.87 - $0.89
Year Range
$0.87 - $2.52
Volume
343
Average Traded
$0.88

Alzamend Share Price Chart

Line chart of the Alzamend price trend over the selected period. The price rose overall, ranging from 0.76 to 0.89, ending at 0.76.
$0.87$0.89
L
Show Current Price
H

Alzamend Stock Fundamentals & Key Indicators

Market Cap
$342607.24
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.89
Revenue (TTM)
$0.00
Return On Equity (TTM)
-156.77%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-203.00%

Alzamend Quarterly Profit & Loss

All figures in USD

ParticularsOct 2025Jan 2026Apr 2026Jul 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.00-$2.20-$2.87-$3.03
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-120.00%-30.45%-5.57%

Alzamend Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.88-$9.95-$5.11-$8.77
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A33.13%48.64%-71.62%

Alzamend Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets0.310.430.180.08
Current Assets1.764.180.465.84
Total Assets2.084.60.635.92
Non Current Liabilities0.00.00.00.0
Current Liabilities1.350.633.232.87
Total Liabilities1.350.633.232.87
Shareholders' Equity0.733.97-2.593.05

Alzamend Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating-8.07-6.57-8.27-8.92
Investing0.0-0.3-0.150.0
Financing4.8310.443.650.0

Corporate Actions

Split
Ex-date: 12 May 2025

Split
Ex-date: 16 Jul 2024

Split
Ex-date: 31 Oct 2023

About Alzamend

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.

Alzamend Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.22
$0.87
-30.87%
Oct 2026
$1.54
$1.26
-29.21%
Sep 2026
$1.64
$1.78
+17.11%
Aug 2026
$1.33
$1.52
+19.69%
Jul 2026
$1.30
$1.27
+1.60%
Jun 2026
$1.22
$1.25
+5.93%
May 2026
$1.05
$1.18
+9.77%
Apr 2026
$1.02
$1.07
+0.47%
Mar 2026
$1.96
$1.07
-45.96%
Feb 2026
$2.19
$1.98
-6.60%
Jan 2026
$1.97
$2.12
+21.14%
Dec 2025
$2.16
$1.75
-17.45%

Alzamend Share Price FAQs